First Time Loading...

Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 27.315 EUR 3.74% Market Closed
Updated: Apr 22, 2024

Relative Value

The Relative Value of one BAYN stock under the Base Case scenario is 82.641 EUR. Compared to the current market price of 27.315 EUR, Bayer AG is Undervalued by 67%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BAYN Relative Value
Base Case
82.641 EUR
Undervaluation 67%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
82
Median 3Y
1
Median 5Y
1.1
Industry
2.3
Forward
0.6
vs History
vs Industry
40
Median 3Y
11.4
Median 5Y
11.4
Industry
22.2
Forward
5.1
vs History
95
vs Industry
44
Median 3Y
9.4
Median 5Y
7.5
Industry
16.7
vs History
49
vs Industry
30
Median 3Y
11.3
Median 5Y
9.1
Industry
22.6
vs History
98
vs Industry
66
Median 3Y
1.4
Median 5Y
1.3
Industry
2
vs History
98
vs Industry
69
Median 3Y
1.6
Median 5Y
1.7
Industry
2.5
Forward
1.1
vs History
98
vs Industry
72
Median 3Y
2.7
Median 5Y
2.9
Industry
5
vs History
84
vs Industry
49
Median 3Y
6.5
Median 5Y
6.9
Industry
13.2
Forward
5.2
vs History
63
vs Industry
43
Median 3Y
10.4
Median 5Y
10.4
Industry
16.5
Forward
8
vs History
82
vs Industry
35
Median 3Y
14.8
Median 5Y
11.5
Industry
15.5
vs History
30
vs Industry
19
Median 3Y
19.1
Median 5Y
17.9
Industry
17.2
vs History
98
vs Industry
73
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9

Multiples Across Competitors

BAYN Competitors Multiples
Bayer AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Bayer AG
XETRA:BAYN
26.8B EUR 0.6 -9.1 2.9 6.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
692.4B USD 20.3 132.1 59.7 68.5
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.8 46.6 34.1 37.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
358.2B USD 4.4 8.8 11.8 15.5
US
Merck & Co Inc
NYSE:MRK
321.8B USD 5.4 881.7 43.9 85.7
UK
AstraZeneca PLC
LSE:AZN
174.4B GBP 4.7 36.3 139.4 223.6
CH
Roche Holding AG
SIX:ROG
180.9B CHF 3.1 15.7 8.7 10.2
CH
Novartis AG
SIX:NOVN
177.9B CHF 4.2 13.2 9.6 15.9
US
Pfizer Inc
NYSE:PFE
148.7B USD 2.5 70.2 10.7 15.9
P/E Multiple
Earnings Growth
DE
Bayer AG
XETRA:BAYN
Average P/E: 150.6
Negative Multiple: -9.1
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
132.1
346%
DK
Novo Nordisk A/S
CSE:NOVO B
46.6
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
8.8
-20%
US
Merck & Co Inc
NYSE:MRK
881.7
7 454%
UK
AstraZeneca PLC
LSE:AZN
36.3
168%
CH
Roche Holding AG
SIX:ROG
15.7
26%
CH
Novartis AG
SIX:NOVN
13.2
15%
US
Pfizer Inc
NYSE:PFE
70.2
680%

See Also

Discover More